SCHEMBL14725792

SCHEMBL14725792

CC1(C)c2ccccc2-c2ccc3c(c(-c4ccc5oc6ccccc6c5c4)cc4cc5c(cc(-c6ccc7oc8ccccc8c7c6)c6c7c(ccc65)-c5ccccc5C7(C)C)cc43)c21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
ALOX5 P09917 2/20 0.34
IDO1 P14902 2/20 0.33
NPC1 O15118 2/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PGR P06401 1/20 0.32
CHEK2 O96017 1/20 0.32
CASP3 P42574 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32
AHR P35869 2/20 0.30
CDC25A P30304 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14725796 0.84 ALOX5 (0.44) ALOX5MAPTMEN1ALDH1A1HPGD
SCHEMBL30345822 0.84 HSP90AA1 (0.42) HSP90AA1HSP90AB1ALOX5IDO1NPC1
SCHEMBL14725800 0.81 ALOX5 (0.35) ALOX5MAPTALDH1A1HPGDRAB9A
SCHEMBL19077609 0.81 HSP90AA1 (0.33) HSP90AA1HSP90AB1ALOX5IDO1NPC1
SCHEMBL14725619 0.80 MAPT (0.37) HSP90AA1HSP90AB1ALOX5NPC1MAPT
SCHEMBL17206437 0.80 ALOX5 (0.49) ALOX5MAPTMEN1KMT2APGR
SCHEMBL24285498 0.79 HSP90AA1 (0.36) HSP90AA1HSP90AB1ALOX5IDO1NPC1
SCHEMBL17206438 0.79 PLA2G2A (0.34) ALOX5CASP3SENP7SENP6
SCHEMBL29347939 0.79 CASP3 (0.35) HSP90AA1HSP90AB1ALOX5IDO1NPC1
SCHEMBL17943875 0.79 HSP90AA1 (0.37) HSP90AA1HSP90AB1ALOX5IDO1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255084-B2 Heterocyclic compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-02-09 US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME TRPC1, TRPC4, TRPC6 HSP90AA1 4468/4885HSP90AB1 4619/4885ALOX5 648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.